Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models

Quantitative assessment of tactile allodynia in the rat paw

Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., & Yaksh, T. L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90144-9 · Cited by 7,740 · see citing works

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

Untitled work

Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746 · see citing works

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · see citing works

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125 · see citing works

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression

Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989 · see citing works

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873 · see citing works

Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition

Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,692 · see citing works

Mechanisms of neuropathic pain

Campbell, J. N., & Meyer, R. A. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.021 · Cited by 1,471 · see citing works

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310 · see citing works

The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide

Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006353 · Cited by 882 · see citing works

Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain

Ahn, K., Johnson, D. S., Mileni, M., Beidler, D., Long, J. Z., McKinney, M. K., Weerapana, E., Sadagopan, N., Liimatta, M., Smith, S. E., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.02.013 · Cited by 439 · see citing works

Molecular characterization of human and mouse fatty acid amide hydrolases

Giang, D. K., & Cravatt, B. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2238 · Cited by 429 · see citing works

An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee

Huggins, J. P., Smart, T. S., Langman, S., Taylor, L., & Young, T. (2012) · Pain · doi:10.1016/j.pain.2012.04.020 · Cited by 375 · see citing works

Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides

Kozak, K. R., Crews, B. C., Morrow, J. D., Wang, L.-H., Ma, Y. H., Weinander, R., Jakobsson, P.-J., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206788200 · Cited by 368 · see citing works

Comparative analysis of fatty acid amide hydrolase and cb1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling

Egertová, M., Cravatt, B. F., & Elphick, M. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00145-3 · Cited by 347 · see citing works

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism

Clapper, J. R., Moreno-Sanz, G., Russo, R., Guijarro, A., Vacondio, F., Duranti, A., Tontini, A., Sanchini, S., Sciolino, N. R., Spradley, J. M., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2632 · Cited by 346 · see citing works

Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain

Kinsey, S. G., Long, J. Z., O’Neal, S. T., Abdullah, R. A., Poklis, J. L., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155465 · Cited by 330 · see citing works

Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity

Lichtman, A. H., Leung, D., Shelton, C. C., Saghatelian, A., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069401 · Cited by 329 · see citing works

Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α

LoVerme, J., Russo, R., La Rana, G., Fu, J., Farthing, J., Mattace-Raso, G., Meli, R., Hohmann, A., Calignano, A., & Piomelli, D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111385 · Cited by 316 · see citing works

Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside

Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305 · see citing works

Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia

Lichtman, A. H., Shelton, C. C., Advani, T., & Cravatt, B. F. (2004) · Pain · doi:10.1016/j.pain.2004.01.022 · Cited by 301 · see citing works

Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models

Jayamanne, A., Greenwood, R., Mitchell, V. A., Aslan, S., Piomelli, D., & Vaughan, C. W. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706510 · Cited by 287 · see citing works

Preclinical Assessment of Candidate Analgesic Drugs: Recent Advances and Future Challenges

Negus, S. S., Vanderah, T. W., Brandt, M. R., Bilsky, E. J., Becerra, L. R., & Borsook, D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106377 · Cited by 255 · see citing works

Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons

Wotherspoon, G., Fox, A., McIntyre, P., Colley, S., Bevan, S., & Winter, J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.009 · Cited by 251 · see citing works

Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation

Rom, S., & Persidsky, Y. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9445-9 · Cited by 240 · see citing works

Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain

Ahn, K., Smith, S. E., Liimatta, M. B., Beidler, D. R., Sadagopan, N., Dudley, D. T., Young, T., Wren, P. B., Zhang, Y., Swaney, S. M., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180257 · Cited by 229 · see citing works

Pharmacological Activity of Fatty Acid Amides Is Regulated, but Not Mediated, by Fatty Acid Amide Hydrolase in Vivo

Lichtman, A. H., Hawkins, E. G., Griffin, G., & Cravatt, B. F. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.73 · Cited by 224 · see citing works

A FAAH-Regulated Class of N- Acyl Taurines That Activates TRP Ion Channels

Saghatelian, A., McKinney, M. K., Bandell, M., Patapoutian, A., & Cravatt, B. F. (2006) · Biochemistry · doi:10.1021/bi0608008 · Cited by 213 · see citing works

Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain

Breivogel, C. S., Sim, L. J., & Childers, S. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36967-8 · Cited by 202 · see citing works

Crucial Role of CB₂Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain

Racz, I., Nadal, X., Alferink, J., Baños, J. E., Rehnelt, J., Martín, M., Pintado, B., Gutierrez-Adan, A., Sanguino, E., Manzanares, J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3400-08.2008 · Cited by 195 · see citing works

Cannabinoid receptors undergo axonal flow in sensory nerves

Hohmann, A. G., & Herkenham, M. A. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00220-1 · Cited by 192 · see citing works

The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice

Russo, R., LoVerme, J., La Rana, G., Compton, T. R., Parrott, J., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Calignano, A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119941 · Cited by 182 · see citing works

Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects

Kinsey, S. G., Wise, L. E., Ramesh, D., Abdullah, R., Selley, D. E., Cravatt, B. F., & Lichtman, A. H. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201426 · Cited by 169 · see citing works

Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury

Romero-Sandoval, A., Nutile-McMenemy, N., & DeLeo, J. A. (2008) · Anesthesiology · doi:10.1097/aln.0b013e318167af74 · Cited by 168 · see citing works

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Chang, L., Luo, L., Palmer, J. A., Sutton, S. W., Wilson, S. J., Barbier, A., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706773 · Cited by 166 · see citing works

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Chang, L., Luo, L., Palmer, J. A., Sutton, S., Wilson, S. J., Barbier, A. J., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706699 · Cited by 155 · see citing works

Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry

Weber, A., Ni, J., Ling, K.-H. J., Acheampong, A., Tang‐Liu, D. D., Burk, R. M., Cravatt, B. F., & Woodward, D. F. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300475-jlr200 · Cited by 129 · see citing works

The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model

Ghosh, S., Wise, L. E., Chen, Y., Gujjar, R., Mahadevan, A., Cravatt, B. F., & Lichtman, A. H. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.020 · Cited by 127 · see citing works

Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors Produce Anti-Allodynic Effects in Mice Through Distinct Cannabinoid Receptor Mechanisms

Kinsey, S. G., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.04.001 · Cited by 118 · see citing works

Diclofenac sodium (GP 45840, voltaren), a potent inhibitor of prostaglandin synthetase

Ku, E. C., Wsvary, J. M., & Cash, W. D. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90186-0 · Cited by 114 · see citing works

Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception

Naidu, P. S., Booker, L., Cravatt, B. F., & Lichtman, A. H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143487 · Cited by 114 · see citing works

Discovery of Prostamide F2α and Its Role in Inflammatory Pain and Dorsal Horn Nociceptive Neuron Hyperexcitability

Gatta, L., Piscitelli, F., Giordano, C., Boccella, S., Lichtman, A. H., Maione, S., & Marzo, V. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031111 · Cited by 110 · see citing works

Pharmacological Characterization of the Anandamide Cyclooxygenase Metabolite: Prostaglandin E2 Ethanolamide

Ross, R. A., Craib, S. J., Stevenson, L., Pertwee, R. G., Henderson, A., Toole, J. J., & Ellington, H. C. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.900 · Cited by 110 · see citing works

Regulation of Inflammatory Pain by Inhibition of Fatty Acid Amide Hydrolase

Naidu, P. S., Kinsey, S. G., Guo, T. L., Cravatt, B. F., & Lichtman, A. H. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164806 · Cited by 108 · see citing works

Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions

Sasso, O., Bertorelli, R., Bandiera, T., Scarpelli, R., Colombano, G., Armirotti, A., Moreno-Sanz, G., Reggiani, A., & Piomelli, D. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.02.012 · Cited by 96 · see citing works

Inhibition of Monoacylglycerol Lipase Attenuates Nonsteroidal Anti-Inflammatory Drug-Induced Gastric Hemorrhages in Mice

Kinsey, S. G., Nomura, D. K., O’Neal, S. T., Long, J. Z., Mahadevan, A., Cravatt, B. F., Grider, J. R., & Lichtman, A. H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175778 · Cited by 93 · see citing works

The Selective Cannabinoid Antagonist SR 141716A Blocks Cannabinoid-Induced Antinociception in Rats

Lichtman, A. H., & Martin, B. R. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00121-9 · Cited by 92 · see citing works

Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice

Kinsey, S. G., Naidu, P. S., Cravatt, B. F., Dudley, D. T., & Lichtman, A. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.022 · Cited by 87 · see citing works

Identification and Characterization of Carprofen as a Multitarget Fatty Acid Amide Hydrolase/Cyclooxygenase Inhibitor

Favia, A. D., Habrant, D., Scarpelli, R., Migliore, M., Albani, C., Bertozzi, S. M., Dionisi, M., Tarozzo, G., Piomelli, D., Cavalli, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3011146 · Cited by 82 · see citing works

Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray

Wilson-Poe, A. R., Morgan, M. M., Aicher, S. A., & Hegarty, D. M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.038 · Cited by 79 · see citing works

The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models

Caprioli, A., Coccurello, R., Rapino, C., Serio, S. D., Tommaso, M. D., Vertechy, M., Vacca, V., Battista, N., Pavone, F., Maccarrone, M., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.191403 · Cited by 68 · see citing works

Pharmacological characterization and gene expression profiling of an L5/L6 spinal nerve ligation model for neuropathic pain in mice

Kiso, T., Watabiki, T., Tsukamoto, M., Okabe, M., Kagami, M., Nishimura, K., Aoki, T., & Matsuoka, N. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.031 · Cited by 55 · see citing works

Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS

Koda, N., Tsutsui, Y., Niwa, H., Ito, S., Woodward, D. F., & Watanabe, K. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.02.009 · Cited by 54 · see citing works

Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors

Desroches, J., Charron, S., Bouchard, J., & Beaulieu, P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.006 · Cited by 51 · see citing works

AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: role for cannabinoid receptors

La Rana, G., Russo, R., D'Agostino, G., Sasso, O., Raso, G. M., Iacono, A., Meli, R., Piomelli, D., & Calignano, A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.021 · Cited by 42 · see citing works

Prostamide F2 α receptor antagonism combined with inhibition of FAAH may block the pro‐inflammatory mediators formed following selective FAAH inhibition

Ligresti, A., Martos, J. L., Wang, J. W., Guida, F., Allarà, M., Palmieri, V., Luongo, L., Woodward, D. F., & Marzo, V. D. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12410 · Cited by 35 · see citing works

Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen

Cipriano, M., Björklund, E., Wilson, A. A., Congiu, C., Onnis, V., & Fowler, C. J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.065 · Cited by 33 · see citing works

Cannabinoids and Pain: New Insights From Old Molecules

Vuckovic, S. M., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 417 · see citing works

Breaking barriers to novel analgesic drug development

Yekkirala, A. S., Roberson, D. P., Bean, B. P., & Woolf, C. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.87 · Cited by 366 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

The cannabinoid system and pain

Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.015 · Cited by 272 · see citing works

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2Receptor Agonists

Tabrizi, M. A., Baraldi, P. G., Borea, P. A., & Varani, K. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00411 · Cited by 110 · see citing works

Cannabis-Based Medicines and Pain: A Review of Potential Synergistic and Entourage Effects

Anand, U., Pacchetti, B., Anand, P., & Sodergren, M. H. (2021) · Pain Management · doi:10.2217/pmt-2020-0110 · Cited by 128 · see citing works

Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model

Barnes, N. S. A., Mitchell, V. A., Kazantzis, N. P., & Vaughan, C. W. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13337 · Cited by 70 · see citing works

Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain

Blanton, H. L., Brelsfoard, J., Deturk, N., Pruitt, K., Narasimhan, M., Morgan, D. J., & Guindon, J. (2019) · Drugs · doi:10.1007/s40265-019-01132-x · Cited by 70 · see citing works

Clinical studies and anti‐inflammatory mechanisms of treatments

French, J. A., Koepp, M. J., Naegelin, Y., Vigevano, F., Auvin, S., Rho, J. M., Rosenberg, E. C., Devinsky, O., Olofsson, P. S., & Dichter, M. A. (2017) · Epilepsia · doi:10.1111/epi.13779 · Cited by 54 · see citing works

Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems—A Novel Treatment Option for Chronic Pain Management

Małek, N., & Starowicz, K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00257 · Cited by 51 · see citing works

Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain

Hossain, M. Z., Ando, H., Unno, S., & Kitagawa, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041423 · Cited by 52 · see citing works

The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review

Fowler, C. J. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_4 · Cited by 45 · see citing works

Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice

Crowe, M. S., Leishman, E., Banks, M. L., Gujjar, R., Mahadevan, A., Bradshaw, H. B., & Kinsey, S. G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13012 · Cited by 45 · see citing works

Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies

Migliore, M., Habrant, D., Sasso, O., Albani, C., Bertozzi, S. M., Armirotti, A., Piomelli, D., & Scarpelli, R. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.12.036 · Cited by 44 · see citing works

6-Methoxyflavanone abates cisplatin-induced neuropathic pain apropos anti-inflammatory mechanisms: A behavioral and molecular simulation study

Akbar, S., Subhan, F., Shahid, M. M., Wadood, A., Shahbaz, N., Farooq, U., Ayaz, M., & Raziq, N. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172972 · Cited by 35 · see citing works

Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritis

Pajak, A., Kostrzewa, M., Małek, N., Korostyński, M., & Starowicz, K. (2017) · Journal of Pain Research · doi:10.2147/jpr.s132682 · Cited by 32 · see citing works

TRPV1–FAAH–COX: The Couples Game in Pain Treatment

Aiello, F., Carullo, G., Badolato, M., & Brizzi, A. (2016) · ChemMedChem · doi:10.1002/cmdc.201600111 · Cited by 30 · see citing works

Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases

Chicca, A., Arena, C., & Manera, C. (2016) · Recent Patents on CNS Drug Discovery · doi:10.2174/1574889810999160603185126 · Cited by 29 · see citing works

Inhibition of Fatty Acid Amide Hydrolase (FAAH) by Macamides

Alasmari, M. M., Bӧhlke, M., Kelley, C. J., Maher, T. J., & Pino‐Figueroa, A. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1115-8 · Cited by 28 · see citing works

Evaluation of different drug classes on transient sciatic nerve injury–depressed marble burying in mice

Wilkerson, J. L., Curry, Z. A., Kinlow, P. D., Mason, B. L., Hsu, K., van der Stelt, M., Cravatt, B. F., & Lichtman, A. H. (2018) · Pain · doi:10.1097/j.pain.0000000000001199 · Cited by 26 · see citing works

CannabinEYEds: The Endocannabinoid System as a Regulator of the Ocular Surface Nociception, Inflammatory Response, Neovascularization and Wound Healing

Aiello, F., Afflitto, G. G., Li, J.-P. O., Martucci, A., Cesareo, M., & Nucci, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124036 · Cited by 24 · see citing works

The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice

Crowe, M. S., Wilson, C. D., Leishman, E., Prather, P. L., Bradshaw, H. B., Banks, M. L., & Kinsey, S. G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14055 · Cited by 20 · see citing works

A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation

Scarpelli, R., Sasso, O., & Piomelli, D. (2015) · ChemMedChem · doi:10.1002/cmdc.201500395 · Cited by 21 · see citing works

Advances in the Treatment of Chronic Pain by Targeting GPCRs

Che, T. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00644 · Cited by 21 · see citing works

Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats

Zubrzycki, M., Janecka, A. E., Liebold, A., Ziegler, M., & Zubrzycka, M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13970 · Cited by 20 · see citing works

The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets

Iannotti, F. A., & Marzo, V. D. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100070 · Cited by 21 · see citing works

Effect of inflammatory factor‐induced cyclo‐oxygenase expression on the development of reperfusion‐related no‐reflow phenomenon in acute myocardial infarction

Jiao, Q., Ke, Q., Li, W., Jin, M., Luo, Y., Zhang, L., Yang, D. H., & Zhang, X. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12339 · Cited by 15 · see citing works

Inhibition of macrophage MAPK/NF-κB pathway and Th2 axis by mangiferin ameliorates MC903-induced atopic dermatitis

Lu, C., Deng, S., Liu, Y., Yang, S., Qin, D., Zhang, L., Wang, R., & Zhang, Y. C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112038 · Cited by 14 · see citing works

Characterization of Mechanical Allodynia and Skin Innervation in a Mouse Model of Type-2 Diabetes Induced by Cafeteria-Style Diet and Low-Doses of Streptozotocin

Castañeda‐Corral, G., Velázquez-Salazar, N. B., Martínez-Martínez, A., Taboada-Serrano, J. N., Núñez-Aragón, P. N., González-Palomares, L., Acosta‐González, R. I., Petricevich, V. L., Acevedo‐Fernández, J. J., Montes, S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.628438 · Cited by 14 · see citing works

Therapeutic Effect of the Substrate-Selective COX-2 Inhibitor IMMA in the Animal Model of Chronic Constriction Injury

Jones, M., Wen, J., Selvaraj, P., Tanaka, M., Moran, S., & Zhang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01481 · Cited by 14 · see citing works

Behavioral Battery for Testing Candidate Analgesics in Mice. II. Effects of Endocannabinoid Catabolic Enzyme Inhibitors and ∆9-Tetrahydrocannabinol

Diester, C. M., Lichtman, A. H., & Negus, S. S. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000497 · Cited by 13 · see citing works

Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases

Thapa, D., Warne, L. N., & Falasca, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914677 · Cited by 12 · see citing works

On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence

Paredes-Ruiz, K. J., Chavira-Ramos, K., Orozco‐Morales, M., Karasu, Ç., Tinkov, A. A., Aschner, M., Santamarı́a, A., & Colín-González, A. L. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00424-z · Cited by 10 · see citing works

Medial prefrontal cortex diclofenac-induced antinociception is mediated through GPR55, cannabinoid CB1, and mu-opioid receptors of this area and periaqueductal gray

Tamaddonfard, E., Erfanparast, A., Salighedar, R., & Tamaddonfard, S. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01735-x · Cited by 9 · see citing works

Therapeutic Effects of Combined Treatment with the AEA Hydrolysis Inhibitor PF04457845 and the Substrate Selective COX-2 Inhibitor LM4131 in the Mouse Model of Neuropathic Pain

Wen, J., Sackett, S., Tanaka, M., & Zhang, Y. (2023) · Cells · doi:10.3390/cells12091275 · Cited by 9 · see citing works

Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies

Vimal, D., D’Souza, L. C., Rai, V., Lal, S., Sharma, A., & Gupta, S. C. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220525124818 · Cited by 8 · see citing works

Technological development of microemulsions with perspectives for pain treatment: a patent review

Lima, M. P. D., Lopes, E. M., Gomes, L. D. S., França, A. R. D. S., Acha, B. T., Carvalho, A. L. M., & Almeida, F. R. D. C. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1519025 · Cited by 7 · see citing works

A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependence

Guindon, J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.018 · Cited by 6 · see citing works

N-arylmethylideneaminophthalimide: Design, Synthesis and Evaluation as Analgesic and Anti-inflammatory Agents

Banarouei, N., Davood, A., Shafaroodi, H., Saeedi, G., & Shafiee, A. (2018) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557518666180424101009 · Cited by 4 · see citing works

Hybrid Analogues of Hydrazone and Phthalimide: Design, Synthesis, In vivo, In vitro, and In silico Evaluation as Analgesic Agents

Shokri, S., Ayazi, H., Tamjid, M., Ghoreishi, F., Shokri, M., Badakhshannouri, S., Naderi, N., Daraei, B., Mousavi, Z., & Davood, A. (2023) · Current Computer - Aided Drug Design · doi:10.2174/1573409919666230517121726 · Cited by 3 · see citing works

Anti-inflammatory and analgesic potential of minor cannabinoids in vivo

Vanegas, S. O., Gamage, T. F., Maturano, J., Šarlah, D., & Kinsey, S. G. (2026) · Journal of Cannabis Research · doi:10.1186/s42238-025-00384-7 · Cited by 2 · see citing works

Nanotherapeutic formulations of enzyme inhibitors targeting cancer and neuroinflammation: An updated review

Liu, Y., Thiruvengadam, M., Arcot, R., Shariati, M. A., Edis, Z., Chung, I.-M., Liu, S., & Xi, Q. (2025) · Industrial Crops and Products · doi:10.1016/j.indcrop.2025.121803 · Cited by 1 · see citing works

Modifying tetramethyl–nitrophenyl–imidazoline with amino acids: design, synthesis, and 3D-QSAR for improving inflammatory pain therapy

Peng, S., Mei, S., Wang, Y., Zhu, H., Wang, Y., Zhao, M., Zhao, S., Wu, J., & Li, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s76218 · Cited by 1 · see citing works

Fatty acid amide hydrolase activity in the dorsal periaqueductal gray attenuates neuropathic pain and associated dysautonomia

Woyach, V. L., Sherman, K., Hillard, C. J., Hopp, F. A., Hogan, Q. H., & Dean, C. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00073.2022 · Cited by 1 · see citing works

2-Arachodonoylglycerol-mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in micePreprint

Morgan, A., Adank, D. N., Johnson, K., Blunt, E., & Patel, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.15.480609 · Cited by 1 · see citing works

Endocannabinoid modulation of secretory and inflammatory causes of gastric pathology

Crowe, M. S. (2016) · doi:10.33915/etd.5412

Behavioral and Anti-inflammatory Effects of MAGL Inhibition in a Mouse Model of Inflammatory Arthritis

Steele, F. F. (2019) · doi:10.33915/etd.4114

Endocannabinoids in pain modulation

Chapman, V., & Woodhams, S. G. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00010-4

The Endocannabinoid System’s Contribution to Placebo AnalgesiaPreprint

Tomin, R., Murray, K., Hadjis, G. E., Khalil, O., Sexton, C. A., Bourke, S. L., Khan, J. S., Finn, D. P., Atlas, L. Y., & Moayedi, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.25.707676

Fatty acid amide hydrolase (FAAH) inhibitor reduces persistent inflammatory pain in mice depending on μ- and δ-opioid receptors activity: Involvement of heme oxygenase-1

Pansarim, V., Tiballi, A. A. F., Pol, O., & Leite‐Panissi, C. R. A. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116329

BindingDB Entry 50047197: Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.

BindingDB (2017) · UC San Diego · doi:10.7270/q21c1zrj

Brain research subject index 1994 volumes 633–668

(1994) · Brain Research · doi:10.1016/0006-8993(94)90301-8

The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1

Fowler, C., Naidu, P., Lichtman, A. H., & Onnis, V. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00029.x · Cited by 57 · see citing works

Therapeutic Effects of Combined Treatment with the AEA Hydrolysis Inhibitor PF04457845 and the Substrate Selective COX-2 Inhibitor LM4131 in the Mouse Model of Neuropathic Pain

Wen, J., Sackett, S., Tanaka, M., & Zhang, Y. (2023) · Cells · doi:10.3390/cells12091275 · Cited by 9 · see citing works

Targeting FAAH and COX to Treat Visceral Pain

Lichtman, A. H., Naidu, P. S., Booker, L., Boger, D. L., & Cravatt, B. F. (2008) · The FASEB Journal · doi:10.1096/fasebj.22.1_supplement.1125.12 · Cited by 2 · see citing works

Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain

Guindon, J., & Beaulieu, P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.12.002 · Cited by 90 · see citing works